Tec Kinases Mediate Sustained Calcium Influx Via Site-specific Tyrosine Phosphorylation of the Phospholipase Cgamma Src Homology 2-Src Homology 3 Linker
Overview
Authors
Affiliations
Tyrosine phosphorylation of phospholipase Cgamma2 (PLCgamma2) is a crucial activation switch that initiates and maintains intracellular calcium mobilization in response to B cell antigen receptor (BCR) engagement. Although members from three distinct families of non-receptor tyrosine kinases can phosphorylate PLCgamma in vitro, the specific kinase(s) controlling BCR-dependent PLCgamma activation in vivo remains unknown. Bruton's tyrosine kinase (Btk)-deficient human B cells exhibit diminished inositol 1,4,5-trisphosphate production and calcium signaling despite a normal inducible level of total PLCgamma2 tyrosine phosphorylation. This suggested that Btk might modify a critical subset of residues essential for PLCgamma2 activity. To evaluate this hypothesis, we generated site-specific phosphotyrosine antibodies recognizing four putative regulatory residues within PLCgamma2. Whereas all four sites were rapidly modified in response to BCR engagement in normal B cells, Btk-deficient B cells exhibited a marked reduction in phosphorylation of the Src homology 2 (SH2)-SH3 linker region sites, Tyr(753) and Tyr(759). Phosphorylation of both sites was restored by expression of Tec, but not Syk, family kinases. In contrast, phosphorylation of the PLCgamma2 carboxyl-terminal sites, Tyr(1197) and Tyr(1217), was unaffected by the absence of functional Btk. Together, these data support a model whereby Btk/Tec kinases control sustained calcium signaling via site-specific phosphorylation of key residues within the PLCgamma2 SH2-SH3 linker.
Estupinan H, Bouderlique T, He C, Berglof A, Cappelleri A, Frengen N Blood Adv. 2024; 8(8):1981-1990.
PMID: 38507738 PMC: 11024922. DOI: 10.1182/bloodadvances.2024012706.
Del Pino-Molina L, Bravo Gallego L, Soto Serrano Y, Reche Yebra K, Marty Lobo J, Gonzalez Martinez B Front Immunol. 2023; 14:1095123.
PMID: 37197664 PMC: 10183671. DOI: 10.3389/fimmu.2023.1095123.
Sousa B, de Almeida C, Barahona A, Lopes R, Martins-Logrado A, Cavaco M ACS Pharmacol Transl Sci. 2022; 5(11):1156-1168.
PMID: 36407952 PMC: 9667546. DOI: 10.1021/acsptsci.2c00163.
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?.
Geladaris A, Hausler D, Weber M Int J Mol Sci. 2021; 22(7).
PMID: 33801644 PMC: 8038003. DOI: 10.3390/ijms22073461.
Ou Y, Tang Z, Novotny W, Tawashi M, Li T, Coleman H Br J Clin Pharmacol. 2020; 87(7):2926-2936.
PMID: 33336408 PMC: 8359458. DOI: 10.1111/bcp.14707.